US Food and Drug Administration has approved a rotigotine transdermal system for the treatment of Parkinson’s disease (PD) and restless legs syndrome (RLS). [More…]…
According to a study published in Archives of Neurology, atrophy in the hippocampus, the region of the brain known for memory formation and storage, is evident in Parkinson’s disease (PD) patients with cognitive impairment, including early decline known as …
A new research report appearing in the December issue of the FASEB Journal shows how scientists from the United Kingdom have developed a simple blood test to detect Parkinson’s disease even at the earliest stages. The test is possible because …
A study in European Neurology suggests that the human brain in Parkinson’s Disease(PD) tries to compensate for the failure of the basal ganglia motor loop by employing alternative (ipsilateral) motor pathways, indicating that a complex reorganization can also take place …
A new diagnostic imaging technique, gives physicians the first objective test to evaluate patients for Parkinsonian syndromes, such as Parkinson’s disease. Northwestern Memorial Hospital is among the first institutions in the country to offer DaTscan™, the only FDA-approved imaging …